Concepedia

M. Lohmeyer

ML

Statistics

Publications

5

Citations

183

H-Index

5

Active since

1991

Affiliations

Cancer Research UK Scotland Institute(Current)

MRC Cancer Unit

M. Lohmeyer is an author at Cancer Research UK Scotland Institute specializing in cell signaling, life sciences, and pharmacology.

Publications per year

1991–1997

5

Publications

5

Cripto Enhances the Tyrosine Phosphorylation of Shc and Activates Mitogen-activated Protein Kinase (MAPK) in Mammary Epithelial Cells

Subha Kannan, Marta De Santis, M. Lohmeyer et al. · Journal of Biological Chemistry · 1997 · 96 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +16

Chemical Synthesis, Structural Modeling, and Biological Activity of the Epidermal Growth Factor-like Domain of Human<i>Cripto</i>

M. Lohmeyer, Paul M. Harrison, Subha Kannan et al. · Biochemistry · 1997 · 29 citations

Life Sciences, Biochemistry, Molecular Biology +16

The role of intracellular free calcium mobilization in the mechanism of action of antitumour ether lipids SRI 62-834 and ET18-OMe

M. Lohmeyer, Paul Workman · Biochemical Pharmacology · 1993 · 23 citations

Life Sciences, Biochemistry, Pharmacology +11

Growth arrest vs direct cytotoxicity and the importance of molecular structure for the in vitro anti-tumour activity of ether lipids

M. Lohmeyer, Paul Workman · British Journal of Cancer · 1995 · 21 citations

Medicine, Oncology, Pharmacology +14

Platelet-activating factor (PAF) antagonist WEB 2086 does not modulate the cytotoxicity of PAF or antitumour alkyl lysophospholipids ET-18-O-Methyl and SRI 62–834 in HL-60 promyelocytic leukaemia cells

Paul Workman, Jane Donaldson, M. Lohmeyer · Biochemical Pharmacology · 1991 · 14 citations

Medicine, Cell Biology, Pharmacology +10

1–5 of 5